Table 3.
Guidelines/local working group recommendations consulted for treatment of relapsed or refractory Ph(–) B-precursor ALL
| Guideline or local working group recommendation | Number of respondents consulting for treatment n (%)a | |||||
|---|---|---|---|---|---|---|
| France | Germany | Italy | Spain | UK | Total | |
| N = 15 | N = 15 | N = 15 | N = 15 | N = 15 | N = 75 | |
| ASH/ASCO, US | 9 (60) | 3 (20) | 7 (47) | 6 (40) | 4 (27) | 29 (39) |
| EWALL, Europe | 7 (47) | 1 (7) | 2 (13) | 2 (13) | 7 (47) | 19 (25) |
| NCCN, US | 6 (40) | 1 (7) | 5 (33) | 5 (33) | 17 (23) | |
| GMALL, Germany | 1 (7) | 13 (60) | 1 (7) | 1 (7) | 16 (21) | |
| GIMEMA, Italy | 12 (80) | 1 (7) | 13 (17) | |||
| PETHEMA, Spain | 11 (73) | 1 (7) | 12 (16) | |||
| UKALL XII, UK | 1 (7) | 11 (73) | 12 (16) | |||
| HAS, France | 2 (13) | 2 (3) | ||||
| Othersb | 4 (27) | 3 (20) | 7 (9) | |||
aRespondents could select multiple guidelines
bThe following guidelines and/or local working group recommendations were consulted by one respondent for treatment: COOPRALL, France; Onco LR, France; GELA, France; GRAALL, France; BCSH, UK; The Beatson hospital, UKc; UKALL 2011 for young adults, UK; non-specified protocol
cThe Beatson hospital is a cancer centre located in the West of Scotland
ALL, acute lymphoblastic leukaemia; ASCO, American Society of Clinical Oncology; ASH, American Society of Hematology; BCSH, the British Committee for Standards in Haematology; COOPRALL, Protocole Coopérateur de Traitement des Rechutes de Leucémies Aiguës Lymphoblastiques de L’enfant (treatment protocol for relapse of ALL in children); EWALL, European Working group for Adult Lymphoblastic Leukemia; GELA, Groupe d’Etude des Lymphomes de l’Adulte (Study Group of the Adult Lymphoma); GET-LALA, Groupe d’Etude et de Traitement des Leucémie Aiguës Lymphoblastique de l’Adulte (Group for the Study and Treatment of Adult ALL, France); GIMEMA, Gruppo Italiano Malattie EMatologiche dell’Adultodell’Adulto (Italian Group for Haematological Diseases in Adults); GMALL, German Multicenter Study Group for Adult ALL; GOELAMS, Groupe Ouest Est des Leucémies Aiguës et Maladies du Sang (East West Group of Acute Leukemia and Blood Diseases, France); GRAALL, Cooperative group combining the French GET-LALA, the GOELAMS, and the SAKK; HAS, Haute Autorité de Santé (High Authority for Health); NCCN, the National Comprehensive Cancer Network; Onco LR, le réseau régional de Cancérologie en Languedoc Roussillon (regional network of Oncology in Languedoc Roussillon); PETHEMA, Program for Study and Treatment of Malignant Haemopathies, Spanish Society of Haematology; SAKK, Schweizer Arbeitsgemeinschaft für klinische Krebsforschung, Leukämie-Arbeitsgruppe (Swiss Group for Clinical Cancer Research, Leukemia Working Group); UKALL 2011 for young adults, United Kingdom Trial for children and young adults with Acute lymphoblastic Leukaemia and Lymphoma 2011; UKALL XII, Medical Research Council Acute Lymphoblastic Leukemia Trial XII